0001161697-22-000045.txt : 20220111 0001161697-22-000045.hdr.sgml : 20220111 20220111182245 ACCESSION NUMBER: 0001161697-22-000045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220110 FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DENKHAUS DONALD A CENTRAL INDEX KEY: 0001278439 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 22524992 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1500 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 01-10-2022 X0306 4 2022-01-10 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001278439 DENKHAUS DONALD A 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 1 0 0 0 Common stock, par value $0.001 per share 2022-01-10 4 M 0 40000 2.53 A 317666 D Options to purchase common stock 2.53 2022-01-10 4 M 0 40000 0 D 2022-12-30 Common Stock 40000 284834 D Derivative securities vested in two equal tranches beginning on December 30, 2015. /s/ Donald A. Denkhaus 2022-01-11